Susceptibility of Pseudomonas aeruginosa to fluoroquinolones following four years of use in a tertiary care hospital.
Of 121 recent clinical isolates of Pseudomonas aeruginosa, 22% were resistant to ciprofloxacin, 50% to ofloxacin and 69% to pefloxacin. Resistance to these drugs was commonest among urinary isolates (P less than 0.03). Cross-resistance was noted between fluoroquinolones and aminoglycosides or beta-lactams.
Shalit
I
I
Infectious Diseases Unit, Tel-Aviv Sourasky Medical Centre, Israel.
Haas
H
H
Berger
S A
SA
D000890:Anti-Infective Agents / Q000494:pharmacology*; D003428:Cross Infection / Q000097:blood / Q000382:microbiology / Q000652:urine; D004352:Drug Resistance, Microbial; D024841:Fluoroquinolones; D006801:Humans; D011552:Pseudomonas Infections / Q000097:blood / Q000382:microbiology / Q000652:urine; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D013183:Sputum / Q000382:microbiology; D014947:Wounds and Injuries / Q000382:microbiology
D000890:Anti-Infective Agents; D024841:Fluoroquinolones